Sunshine Biopharma Inc. (SBFMW) stock
SBFMWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFM
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.03+0.00 (+2.00%)
Close on Oct 30, 2026Market cap $11.36MP/E –Yield –
Sunshine Biopharma cash
Cash and short-term investments held at the end of each period.
Sunshine Biopharma's cash was $13.75M at Jun 30, 2026. For fiscal 2025 it was $9.12M, down 5.8% from the year before. Over ten years it grew 68.0% a year on average. The highest annual figure on record is $21.83M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.12M | -5.8% |
| FY2024 | Dec 31, 2024 | $9.69M | -40.5% |
| FY2023 | Dec 31, 2023 | $16.29M | -25.4% |
| FY2022 | Dec 31, 2022 | $21.83M | +967.2% |
| FY2021 | Dec 31, 2021 | $2.05M | +106.6% |
| FY2020 | Dec 31, 2020 | $989.89K | +2344.1% |
| FY2019 | Dec 31, 2019 | $40.50K | -64.8% |
| FY2018 | Dec 31, 2018 | $115.22K | +7.1% |
| FY2017 | Dec 31, 2017 | $107.53K | +87.2% |
| FY2016 | Dec 31, 2016 | $57.45K | +13.1% |
| FY2015 | Dec 31, 2015 | $50.80K | -64.6% |
| FY2014 | Dec 31, 2014 | $143.42K | +359.1% |
| FY2013 | Dec 31, 2013 | $31.24K | -76.4% |
| FY2012 | Dec 31, 2012 | $132.64K | +118.5% |
| FY2011 | Dec 31, 2011 | $60.69K | -62.6% |
| FY2010 | Dec 31, 2010 | $162.39K | +44.8% |
| FY2009 | Dec 31, 2009 | $112.12K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $13.75M | +33.4% |
| Q1 FY2026 | Mar 31, 2026 | $6.91M | -14.9% |
| Q4 FY2025 | Dec 31, 2025 | $9.12M | -5.8% |
| Q3 FY2025 | Sep 30, 2025 | $9.31M | -23.8% |
| Q2 FY2025 | Jun 30, 2025 | $10.31M | -10.4% |
| Q1 FY2025 | Mar 31, 2025 | $8.12M | -53.4% |
| Q4 FY2024 | Dec 31, 2024 | $9.69M | -40.5% |
| Q3 FY2024 | Sep 30, 2024 | $12.21M | -35.2% |
| Q2 FY2024 | Jun 30, 2024 | $11.51M | -41.7% |
| Q1 FY2024 | Mar 31, 2024 | $17.43M | -9.6% |
| Q4 FY2023 | Dec 31, 2023 | $16.29M | -25.4% |
| Q3 FY2023 | Sep 30, 2023 | $18.85M | -53.5% |
| Q2 FY2023 | Jun 30, 2023 | $19.73M | -52.7% |
| Q1 FY2023 | Mar 31, 2023 | $19.29M | +46.4% |
| Q4 FY2022 | Dec 31, 2022 | $21.83M | +967.2% |
| Q3 FY2022 | Sep 30, 2022 | $40.56M | +1599.3% |
| Q2 FY2022 | Jun 30, 2022 | $41.73M | +2304.9% |
| Q1 FY2022 | Mar 31, 2022 | $13.18M | +633.5% |
| Q4 FY2021 | Dec 31, 2021 | $2.05M | +106.6% |
| Q3 FY2021 | Sep 30, 2021 | $2.39M | +388.4% |
| Q2 FY2021 | Jun 30, 2021 | $1.74M | +1927.1% |
| Q1 FY2021 | Mar 31, 2021 | $1.80M | +16522.8% |
| Q4 FY2020 | Dec 31, 2020 | $989.89K | +2344.1% |
| Q3 FY2020 | Sep 30, 2020 | $488.71K | +496.2% |
| Q2 FY2020 | Jun 30, 2020 | $85.59K | +129.6% |
| Q1 FY2020 | Mar 31, 2020 | $10.81K | -88.6% |
| Q4 FY2019 | Dec 31, 2019 | $40.50K | -64.8% |
| Q3 FY2019 | Sep 30, 2019 | $81.97K | +76.6% |
| Q2 FY2019 | Jun 30, 2019 | $37.28K | +2.4% |
| Q1 FY2019 | Mar 31, 2019 | $95.13K | -9.2% |
| Q4 FY2018 | Dec 31, 2018 | $115.22K | +7.1% |
| Q3 FY2018 | Sep 30, 2018 | $46.43K | -75.3% |
| Q2 FY2018 | Jun 30, 2018 | $36.40K | -71.7% |
| Q1 FY2018 | Mar 31, 2018 | $104.76K | +511.1% |
| Q4 FY2017 | Dec 31, 2017 | $107.53K | +87.2% |
| Q3 FY2017 | Sep 30, 2017 | $188.09K | +763.2% |
| Q2 FY2017 | Jun 30, 2017 | $128.77K | – |
| Q1 FY2017 | Mar 31, 2017 | $17.14K | – |
| Q4 FY2016 | Dec 31, 2016 | $57.45K | – |
| Q3 FY2016 | Sep 30, 2016 | $21.79K | – |